A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients
- 1 February 2001
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (2) , 183-193
- https://doi.org/10.1016/s0301-472x(00)00651-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular LymphomaBlood, 1999
- Clinical relevance of minimal residual disease monitoring in non-Hodgkin’s lymphomas: a critical reappraisal of molecular strategiesLeukemia, 1999
- Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissionsLeukemia, 1999
- Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)Bone Marrow Transplantation, 1999
- Should we purge?Bone Marrow Transplantation, 1998
- Bone Marrow Versus Peripheral Blood Progenitor Cells CD34 Selection in Patients With Non-Hodgkin's Lymphomas: Different Levels of Tumor Cell Reduction. Implications for AutograftingBlood, 1997
- Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphomaBlood, 1995
- Purging of peripheral blood stem cell graftsThe International Journal of Cell Cloning, 1995
- All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatmentBlood, 1991
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991